Logo image of DOVA

Dova Pharmaceuticals Inc. (DOVA) Stock Fundamental Analysis

USA - NASDAQ:DOVA -

28.04
+0.04 (+0.14%)
Last: 11/11/2019, 9:00:22 PM
28.04
0 (0%)
After Hours: 11/11/2019, 9:00:22 PM
No Fundamental Analysis report for DOVA not available.

Dova Pharmaceuticals Inc.

NASDAQ:DOVA (11/11/2019, 9:00:22 PM)

After market: 28.04 0 (0%)

28.04

+0.04 (+0.14%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners33.03%
Inst Owner Change0%
Ins Owners43.01%
Ins Owner Change0%
Market Cap807.61M
Revenue(TTM)13.73M
Net Income(TTM)-74.06M
Analysts76
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)0%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 58.81
P/FCF N/A
P/OCF N/A
P/B 24.3
P/tB N/A
EV/EBITDA -10.72
EPS(TTM)-2.56
EYN/A
EPS(NY)-1.8
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.48
BVpS1.15
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -93.81%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -531.55%
PM (TTM) -539.32%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.08
Quick Ratio 4.77
Altman-Z 5.25
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
EPS Next Y6.15%
EPS Next 2Y16.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)82.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Dova Pharmaceuticals Inc. / DOVA FAQ

What is the ChartMill fundamental rating of Dova Pharmaceuticals Inc. (DOVA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to DOVA.


What is the valuation status for DOVA stock?

ChartMill assigns a valuation rating of 0 / 10 to Dova Pharmaceuticals Inc. (DOVA). This can be considered as Overvalued.


Can you provide the profitability details for Dova Pharmaceuticals Inc.?

Dova Pharmaceuticals Inc. (DOVA) has a profitability rating of 0 / 10.


Can you provide the financial health for DOVA stock?

The financial health rating of Dova Pharmaceuticals Inc. (DOVA) is 5 / 10.


What is the earnings growth outlook for Dova Pharmaceuticals Inc.?

The Earnings per Share (EPS) of Dova Pharmaceuticals Inc. (DOVA) is expected to grow by 6.15% in the next year.